• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Luiro

Head of Nordic ER Development, Analyst

Antti Luiro portrait

Coverage

LeadDeskNightingale HealthAiforia TechnologiesQt Group

Latest content

ShowingAll content types

Nightingale: We factored the project delay into our estimates

Research 12.06.2026, 09.20 by Antti Siltanen, Antti Luiro
Nightingale Health

Qt's restruktureringsforhandlinger i Finland er afsluttet

Analyst Comment 05.06.2026, 07.34 by Antti Luiro
Qt Group

Qt Group Q1'26: Aktien handles stadig med frygt i front

Research 15.05.2026, 07.57 by Antti Luiro
Qt Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

M&A activity in digital pathology is increasing

Analyst Comment 15.05.2026, 08.45 by Antti Siltanen, Antti Luiro
Aiforia Technologies

Qt Group Q1'26 preview: IAR kompenserer for organisk svaghed

Analyst Comment 04.05.2026, 06.00 by Antti Luiro
Qt Group

LeadDesk Q1'26: En sort-hvid investeringscase holder os på tæerne

Research 26.04.2026, 19.32 by Frans-Mikael Rostedt, Antti Luiro
LeadDesk

LeadDesk Q1'26 preview: Indtjeningsvæksten skal fortsætte, mens investorernes frygt for AI vokser

Analyst Comment 21.04.2026, 06.30 by Frans-Mikael Rostedt, Antti Luiro
LeadDesk

Qt's udnævnelse af finansdirektør skaber kontinuitet midt i integrationen

Analyst Comment 08.04.2026, 07.24 by Antti Luiro
Qt Group

Qt Group Q4'25: Sentiment is glum and expectations are moderate

Research 27.02.2026, 12.28 by Antti Luiro, Atte Riikola
Qt Group

Qt Group Q4'25 preview: Søger bekræftelse på indtjeningsvækstforventninger

Analyst Comment 24.02.2026, 06.40 by Antti Luiro, Atte Riikola
Qt Group